Why the study?
T2D is a risk factor for cognitive impairment, but the role of glycemia changes over time in cognitive impairment risk remains unclear.
Does HbA1c trajectory over 20 years increase the risk of cognitive impairment in adults with prediabetes or T2D?
Population
1,682 middle-aged adults with pre-diabetes at enrollment
Comparison
Longitudinal HbA1c trajectory (intercept and slope)
Design
Cohort study
Follow-up
20 years of follow-up
Key result
Higher mean HbA1c was associated with a higher risk for amnestic mild cognitive impairment independent of demographics (OR 1.77; 95% CI 1.06-2.97; p=0.03), but not after full covariate adjustment.
Authors
Loading...
Mean HbA1c does not independently predict aMCI after full adjustment; leaves open glycemic effects on cognition in prediabetes.
Cohort (n=1,682)
Does HbA1c trajectory over 20 years increase the risk of cognitive impairment in adults with prediabetes or T2D?
Odds Ratio: 1.77 (95% CI 1.06–2.97)
p-value: p=0.03
Long-term glycemia trajectories in prediabetes and T2D do not independently confer risk for cognitive impairment when accounting for established demographic, genetic, and cardiovascular risk factors.
Shapiro et al. (2026) conducted a cohort in Pre-diabetes or Type 2 Diabetes (n=1,682). Higher mean HbA1c (glycemia trajectory) vs. Lower mean HbA1c was evaluated on Prevalent cognitive impairment (CI) assessed 25 years after enrollment (OR 1.77, 95% CI 1.06-2.97, p=0.03). Higher mean HbA1c was associated with a higher risk for amnestic mild cognitive impairment independent of demographics (OR 1.77; 95% CI 1.06-2.97; p=0.03), but not after full covariate adjustment.